Transformative Impact of Proteomics on Cardiovascular Health and Disease
Published: July 20, 2015
- The American Heart Association (AHA) summarizes advances in proteomics over the past 20 years that have catalyzed the capacity to address the experimental, translational, and clinical implications as applied to cardiovascular health and disease.
- The statement extends beyond the typical literature review and offers guidance on the use of next-generation proteomics for future scientific discovery in the basic research laboratory and clinical settings.
- Key successes that have energized the field are delineated in this statement; opportunities for proteomics to drive basic science research, facilitate clinical translation, and established diagnostic and therapeutic healthcare algorithms are discussed.
- Challenges that remain to be solved before proteomic technologies can be readily translated from scientific discoveries to meaningful advances in cardiovascular care are also addressed.
The Transformative Impact of Proteomics on Cardiovascular Health and Disease
Merry Lindsey, PhD, lead author, announces the publication of "The Transformative Impact of Proteomics on Cardiovascular Health and Disease: A Scientific Statement from the American Heart Association," which evaluates the current status of the proteomics field and offers guidance on the use of next-generation techniques for future scientific discoveries in cardiovascular medicine.
Supporting Materials
Recommended Reading
- Future Translational Applications From the Contemporary Genomics Era
- Basic Concepts and Potential Applications of Genetics and Genomics for Cardiovascular and Stroke Clinicians
- Top Advances in Functional Genomics and Translational Biology for 2014
- Genetics and Genomics for the Prevention and Treatment of Cardiovascular Disease Update
- Genetics and Cardiovascular Disease